期刊文献+

奥沙利铂-姜黄素脂质体复合物的制备及质量评价

Preparation and Quality Evaluation of Liposome Complex of Oxaliplatin and Curcumin
下载PDF
导出
摘要 目的:制备共载奥沙利铂-姜黄素脂质体复合物,并对其质控方法进行评价。方法:采用薄膜分散-被动载药技术制备脂质复合物,建立高效液相色谱法测定脂质体复合物含量及包封率,采用Malvern粒度仪测定Zeta电位、动态光散射技术测定粒度与粒度分布。结果:奥沙利铂-姜黄素脂质体复合物的包封率分别为99.02%、97.97%,Zeta电位为(-8.36±1.8)m V;平均粒径为(134.6±1.9)nm,D_(10)(99.2±2.2)nm,D_(50)(137±1.7)nm,D_(90)(189±1.1)nm,D_(100)(248±1.6)nm;脂质体复合物于5℃±3℃稳定性考察6个月,各项考察指标均在标准规定范围内。结论:该技术适合奥沙利铂-姜黄素脂质体复合体的制备,建立的质控方法简单、准确,适合对该脂质体复合物的性质进行评价。 Objective: To prepare liposome complex loading oxaliplatin and curcumin, and evaluate its pharmaceutical properties. Methods: A film dispersion-passive drug-loading technology was used to entrap oxaliplatin and curcumin for preparing liposome complex. An HPLC method was established for determining oxaliplatin and curcumin. The mean diameter of liposome complex was determined by dynamic light scattering(DLS) techniques. Results: The entrapment efficiency of oxaliplatin and curcumin was 99.02% and97.97%, respectively. The Zeta potential was(-8.36±1.8) m V, and the mean diameter was(134.6±1.9) nm with D10at(99.2±2.2) nm, D50at(137±1.7) nm, D90(189±1.1) nm and D100at(248±1.6) nm. The inspection indexes of the liposome complex met the specification of stability test for 6 months at(5 ℃±3 ℃). Conclusion: The technology is fit to prepare the liposome complex of oxaliplatin and curcumin. The analysis method is simple and accurate which can be used to evaluate the property of the liposome complex.
出处 《药学与临床研究》 2017年第1期1-5,共5页 Pharmaceutical and Clinical Research
关键词 奥沙利铂 姜黄素 脂质复合物 质量评价 制备 Oxaliplatin Curcumin Liposome complex Quality evalution Preparation
  • 相关文献

参考文献2

  • 1Xin Zhang, Xin-Rong Yang, Xiao-Wu Huang, Wei-Min Wang, Ruo-Yu Shi, Yang Xu, Zheng Wang, Shuang-Jian Qiu, Jia Fan ,Jian Zhou Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai Key Laboratory for Organ Transplantation, Shanghai 200032, China,Institute of Biomedical Sciences, Fudan University, Shanghai 200032, China.Sorafenib in treatment of patients with advanced hepatocellular carcinoma:a systematic review[J].Hepatobiliary & Pancreatic Diseases International,2012,11(5):458-466. 被引量:29
  • 2国家药典委员会编..中华人民共和国药典 2015年版 一部[M].北京:中国医药科技出版社,2015:1810.

二级参考文献1

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部